AI in Drug Discovery
A company leveraging AI is revolutionizing drug discovery by analyzing chemical markers and previous drug data to expedite the development of new treatments. With a significant partnership with OpenAI and a pipeline of promising drugs, the potential for investment in this sector is projected to reach $5 billion by 2028. This innovative approach not only streamlines the costly and time-consuming process of drug development but also highlights the meaningful applications of AI beyond traditional uses.In this clip
From this podcast
Equity
AI-powered drug development, VW teams up with Rivian, and DEI is 'bad'
Related Questions